相关实验视频
Updated: Sep 15, 2025

06:37
Immunolabelling Myofiber Degeneration in Muscle Biopsies
Published on: December 5, 2019
9.0K
在MG中血液和数字生物标志物
Amol K Bhandage1, Jiaxin Chen2, Henry J Kaminski2
1Department of Medical Sciences, Clinical Neurophysiology, Uppsala University, Uppsala, Sweden.
International review of neurobiology
|July 17, 2025
概括
生物标志物对于肌痛性骨髓灰质炎 (MG) 的诊断和治疗至关重要. 先进的研究旨在开发个性化治疗的预测生物标志物,改善患者的治疗结果.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 生物标志物发现发现
背景情况:
- 生物标志物对于诊断和管理神经肌肉疾病 - - 肌痛性肌痛症 (MG) 是必不可少的.
- 目前的MG诊断依赖于对乙胆受体 (AChR) 或肌肉特异性氨酸激酶 (MuSK) 的抗体.
- 针对个性化MG治疗的预测生物标志物仍未得到充分发展.
研究的目的:
- 审查当前的生物标志物在肌痛性骨髓灰质炎的景观.
- 突出新兴生物标志物的潜力,用于诊断,预后和治疗选择.
- 探索MG生物标志物研究的未来方向,包括多omics和数字方法.
主要方法:
- 对MG的诊断,预后和药理动力学生物标志物的文献综述.
- 对当前和新兴生物标记物类别的分析:抗体,微RNA,遗传标记物,代谢物,细胞计数,蛋白质组学和数字生物标记物.
- 讨论多学科和大数据在推动生物标志物发现中的作用.
主要成果:
- 已确定的生物标志物包括用于诊断的ACHR和MuSK抗体.
- 由microRNAs显示的预后潜力 (例如,miR-150-5p,miR-30e-5p).
- 药理动力学标记物,如CD20+ B细胞和CYP3A5基因,为向治疗提供了信息.
结论:
- 生物标志物对于优化MG诊断和治疗至关重要.
- 对预测和预后生物标志物的进一步研究是个性化MG护理所需的.
- 整合多omics和数字技术有望彻底改变MG生物标志物发现和患者管理.
相关概念视频
Myasthenia Gravis: Diagnostic Tests
1.4K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.4K
Myasthenia Gravis: Overview and Treatment
2.0K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.0K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
342
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
342
Chemical Synapses
9.2K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
9.2K
Disorders of the Skeletal Muscle
1.1K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.1K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
218
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
218

